Accelerated cellular senescence in myelodysplastic syndrome

Experimental Hematology

Volumn 37, Issue 11, 2009, Pages 1310-1317

  Wang, Yuan yuan ^a   Cen, Jian nong ^a   He, Jun ^a   Shen, Hong jie ^a   Liu, Dan dan ^a   Li, Yao ^a   Qi, Xiao fei ^a   Chen, Zi xing ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL AGING; CELL STRAIN HL 60; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENESCENCE; UPREGULATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANEMIA, REFRACTORY; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENES, P16; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 70349989871     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.09.002     Document Type: Article

References (32)

1. Fenaux P. Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. Semin Hematol 41 (2004) 6-12
2. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
3. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
4. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
5. Jin M., Piao Z., Kim N.G., et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 89 (2000) 60-68
6. Michaloglou C., Vredeveld L.C., Soengas M.S., et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
7. Collado M., Gil J., Efeyan A., et al. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) 642
8. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
9. Serrano M., and Blasco M.A. Putting the stress on senescence. Curr Opin Cell Biol 13 (2001) 748-753
10. Campisi J. Cellular senescence as a tumour-suppressor mechanism. Trends Cell Biol 11 (2001) S27-S31
11. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16. Cell 88 (1997) 593-602
12. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
13. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
14. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
15. Liu D., Chen Z., Xue Y., et al. The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients. Leuk Res (2009) 1029-1038
16. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
17. Brunning R.D., Bennett J.M., Flandrin G., et al. Myelodysplastic syndromes. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France p. 61-73
18. Cantù Rajnoldi A., Fenu S., Kerndrup G., et al. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol 84 (2005) 429-433
19. Miguel A., Orero M., Simon R., et al. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia. Lab Hematol 13 (2007) 98-102
20. Dimri G.P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci 92 (1995) 9363-9367
21. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
22. Bodnar A.G., Ouellette M., Frolkis M., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
23. Sigal S.H., Rajvanshi P., Gorla G.R., et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 276 (1999) 1260-1272
24. Randle D.H., Zindy F., Sherr C.J., and Roussel M.F. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc Natl Acad Sci U S A 98 (2001) 9654-9659
25. Campisi J., and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8 (2007) 729-740
26. Chen Z., Trotman L.C., Shaffer D., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730
27. Braig M., Lee S., Loddenkemper C., et al. Oncogene induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
28. Yoshida Y. Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 7 (1993) 144-146
29. Raza A., Gezer S., Mundle S., et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86 (1995) 268-276
30. Parker J.E., Mufti G.J., Rasool F., Mijovic A., Devereux S., and Pagliuca A. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood 96 (2000) 3932-3938
31. Mooi W.J., and Peeper D.S. Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 355 (2006) 1037-1046
32. Zhang J., Xue Y., Pan J., et al. Study on the clonal origin of the morphologically dysplastic bone marrow cells in myelodysplastic syndrome by FISH analysis. Zhong hua xue ye xue za zhi (Chin J Hematol.) 30 (2009) 332-334 (in Chinese)